title: Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition.
authors.affiliation: Family Health International, Research Triangle Park, NC, USA.
authors.forename: Charles S
authors.initials: CS
authors.lastname: Morrison
authors.forename: B A
authors.initials: BA
authors.lastname: Richardson
authors.forename: D D
authors.initials: DD
authors.lastname: Celentano
authors.forename: T
authors.initials: T
authors.lastname: Chipato
authors.forename: F
authors.initials: F
authors.lastname: Mmiro
authors.forename: R
authors.initials: R
authors.lastname: Mugerwa
authors.forename: N S
authors.initials: NS
authors.lastname: Padian
authors.forename: S
authors.initials: S
authors.lastname: Rugpao
authors.forename: R A
authors.initials: RA
authors.lastname: Salata
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004343:Drug Implants; D005260:Female; D015658:HIV Infections / Q000209:etiology* / Q000635:transmission; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D011446:Prospective Studies; D012307:Risk Factors; D013785:Thailand; D014454:Uganda; D015030:Zimbabwe
chemical_list: D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004343:Drug Implants; D017258:Medroxyprogesterone Acetate